EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging

Lorraine J Lauwerends, Bo E Zweedijk, Hidde A Galema, Lisanne K A Neijenhuis, Neeltje G Dekker-Ensink, Robert J Baatenburg de Jong, Cornelis Verhoef, Shadhvi S Bhairosingh, Peter J K Kuppen, Alexander L Vahrmeijer, Tessa M van Ginhoven, Senada Koljenović und 3 weitere

Molecular Diagnosis & Therapy · 2024

DOI: 10.1007/s40291-024-00742-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, 2024. Verfasst von Lorraine J Lauwerends und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Head and Neck Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Oral and laryngeal squamous cell carcinoma (OSCC and LSCC) and papillary thyroid carcinoma (PTC) are common head and neck cancers (HNCs) typically treated surgically. Challenges in tumour delineation often lead to inadequate resection margins in OSCC and LSCC, and missed multifocality in PTC. Fluorescence imaging (FLI) using near-infrared tumour-targeting tracers may improve intraoperative identification of malignancy, facilitating precise excision. This study evaluates six potential FLI targets in OSCC, LSCC and PTC. MATERIALS AND METHODS: Immunohistochemical staining was performed on OSCC (n = 20), LSCC (n = 10) and PTC (n = 10), assessing CEA, c-Met, EpCAM, EGFR, integrin αvβ6 and VEGF-α. Expression was scored (0-12) using the total immunostaining score (TIS) system, and categorized into absent (TIS 0), low (TIS 1-5), moderate (TIS 6-8) or high (TIS 9-12). RESULTS: Integrin αvβ6 showed significant overexpression in OSCC (TIS: 12; p < 0.001) and LSCC (TIS: 8; p = 0.002), with 80% of OSCC and 90% of LSCC exhibiting moderate-high expression. Similarly, EGFR expression was moderate-high in most OSCC (87.5%; TIS: 8) and universally high in LSCC (100%; TIS: 12). In PTC, EGFR and VEGF-α expressions were low-moderate, but significantly higher than in healthy tissue (TIS: 6; p < 0.006). CONCLUSION: This study highlights integrin αvβ6 and EGFR as viable FLI targets in OSCC and LSCC, especially integrin αvβ6 for tumour margin delineation. In PTC, despite lower expressions, the significant overexpression of VEGF-α, c-MET, and EGFR suggests their potential as FLI targets. Our findings support the development of tumour-targeted FLI tracers to improve surgical precision in HNC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorHead and Neck NeoplasmsHumansMaleFemaleMiddle AgedCarcinoma, Squamous CellAgedImmunohistochemistryMolecular ImagingAdultThyroid Cancer, PapillarySquamous Cell Carcinoma of Head and NeckErbB Receptors

Substanzen

Biomarkers, TumorErbB Receptors

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
  • Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
  • Centre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Department of Pathology, Antwerp University Hospital, 2650, Antwerp, Belgium.

ORCID-Profile: Stijn Keereweer

Zitieren

APA

Lauwerends, L. J., Zweedijk, B. E., Galema, H. A., Neijenhuis, L. K. A., Dekker-Ensink, N. G., Baatenburg de Jong, R. J., Verhoef, C., Bhairosingh, S. S., Kuppen, P. J. K., Vahrmeijer, A. L., van Ginhoven, T. M., Koljenović, S., Koppes, S. A., Hilling, D. E., & Keereweer, S. (2024). Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00742-w

Vancouver

Lauwerends LJ, Zweedijk BE, Galema HA, Neijenhuis LKA, Dekker-Ensink NG, Baatenburg de Jong RJ, et al. Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging. Molecular Diagnosis & Therapy. 2024. doi:10.1007/s40291-024-00742-w

BibTeX
@article{Lauwerends2024,
  author = {Lauwerends, Lorraine J and Zweedijk, Bo E and Galema, Hidde A and Neijenhuis, Lisanne K A and Dekker-Ensink, Neeltje G and Baatenburg de Jong, Robert J and Verhoef, Cornelis and Bhairosingh, Shadhvi S and Kuppen, Peter J K and Vahrmeijer, Alexander L and van Ginhoven, Tessa M and Koljenović, Senada and Koppes, Sjors A and Hilling, Denise E and Keereweer, Stijn},
  title = {Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging},
  journal = {Molecular Diagnosis & Therapy},
  year = {2024},
  doi = {10.1007/s40291-024-00742-w}
}
Kostenlos starten →